BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.90
-0.50 (-1.64%)
Apr 20, 2026, 1:09 PM CST

BioLASCO Taiwan Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
42.4344.0349.7442.3145.15
Depreciation & Amortization
11.5310.9710.579.969.99
Asset Writedown & Restructuring Costs
-0.06----
Loss (Gain) on Equity Investments
-0.81-1.72-8.72-4.68-2.72
Provision & Write-off of Bad Debts
0.07-0.040.05-0.04
Other Operating Activities
-3.82-5.672.88-2.92
Change in Accounts Receivable
7.555.51-18.37-1.4119.28
Change in Inventory
6.17-4.24-12.73-3.892.27
Change in Accounts Payable
-14.3614.12-2.952.771.26
Change in Unearned Revenue
5.07-6.123.821.3-0.71
Change in Other Net Operating Assets
-5.070.025.17-1.66-6.63
Operating Cash Flow
48.7156.8629.4644.6970.84
Operating Cash Flow Growth
-14.34%93.02%-34.08%-36.92%-3.66%
Capital Expenditures
-21.65-55.83-1.63-3.81-4.23
Sale (Purchase) of Intangibles
--0.11--0.46-0.13
Investment in Securities
-0-42.56-6.75-22.3-12
Other Investing Activities
1.330.89-0.45-2.163.19
Investing Cash Flow
-20.32-97.6-8.83-28.72-13.17
Long-Term Debt Issued
-56---
Long-Term Debt Repaid
-16.09-9.15-7.74-7.65-6.74
Net Debt Issued (Repaid)
-16.0946.85-7.74-7.65-6.74
Common Dividends Paid
-38.42-42.26-38.42-40.98-51.23
Other Financing Activities
0.01----
Financing Cash Flow
-54.54.59-46.16-48.63-57.97
Net Cash Flow
-26.11-36.15-25.53-32.67-0.3
Free Cash Flow
27.061.0427.8340.8866.62
Free Cash Flow Growth
2511.97%-96.28%-31.92%-38.64%-
Free Cash Flow Margin
10.30%0.35%10.51%17.33%29.27%
Free Cash Flow Per Share
1.050.041.081.592.60
Cash Interest Paid
1.951.761.31.090.88
Cash Income Tax Paid
10.2115.969.5410.918.43
Levered Free Cash Flow
27.73-7.4116.4332.9855.9
Unlevered Free Cash Flow
29-6.3217.2433.6656.45
Change in Working Capital
-0.649.28-25.06-2.915.47
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.